| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $100K | +183.4% |
| Cost of Revenue | $0 | — |
| Gross Profit | $100K | +183.4% |
| R&D Expense | $1.1M | +376.4% |
| SG&A Expense | $19.2M | +77.5% |
| Operating Income | -$36.5M | -1198.0% |
| Pre-tax Income | -$33.7M | -187.4% |
| Income Tax | $0 | — |
| Net Income | -$33.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $149K | -91.1% |
| Accounts Receivable | $31K | +208.9% |
| Current Assets | $1.2M | +2633.5% |
| Total Assets | $18.1M | -17.9% |
| Current Liabilities | $14.3M | +77.7% |
| Total Liabilities | $15.5M | +76.6% |
| Stockholders' Equity | $2.6M | +130.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.0M | -1607.1% |
| Capital Expenditures | $53K | +9.7% |
| Investing Cash Flow | -$281K | -100.1% |
| Financing Cash Flow | $12.8M | +104.3% |
| Free Cash Flow | -$14.1M | -1518.4% |
| -390.1% |
| EPS (Basic) | -$1.02 | -78.9% |
| EPS (Diluted) | -$1.02 | -78.9% |